KalVista Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KALV and other ETFs, options, and stocks.About KALV
KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa.
KALV Key Statistics
Stock Snapshot
With a market cap of 931.06M, KalVista Pharmaceuticals(KALV) trades at $18.35. The stock has a price-to-earnings ratio of -4.61.
On 2026-03-11, KalVista Pharmaceuticals(KALV) stock traded between a low of $17.02 and a high of $18.70. Shares are currently priced at $18.35, which is +7.8% above the low and -1.9% below the high.
The KalVista Pharmaceuticals(KALV)'s current trading volume is 1.66M, compared to an average daily volume of 950.76K.
In the last year, KalVista Pharmaceuticals(KALV) shares hit a 52-week high of $19.00 and a 52-week low of $9.24.
In the last year, KalVista Pharmaceuticals(KALV) shares hit a 52-week high of $19.00 and a 52-week low of $9.24.
Analyst ratings
100%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.